Doç. Dr. SERAP ERKEK ÖZHAN

Yayın Ağı

Makaleler 44

1. Modelling neuroendocrine differentiation in bladder cancer and analysis of phenotypic and molecular effects

Boyvath E., Akman B., YÖRÜKOĞLU K., Atabey N., ŞENTÜRK Ş., ERKEK ÖZHAN S.

FEBS OPEN BIO , cilt.15, ss.220, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Silencing of EZH2 in hepatocellular carcinoma alters cancer stemness, drug resistance, and survival pathways

Turan S., Sariyar E., Tercan S. A., ERKEK ÖZHAN S., ERDAL BAĞRIYANIK Ş. E.

FEBS OPEN BIO , cilt.15, ss.263-264, 2025 (SCI-Expanded, Scopus)

3. Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer

Dayanc B., Eris S., Gulfirat N. E., Ozden-Yilmaz G., Cakiroglu E., Coskun Deniz O. S., et al.

CELL DEATH & DISEASE , cilt.16, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Nucleocytoplasmic β-catenin expression contributes to neuroendocrine differentiation in muscle invasive bladder cancer

Akman B., Bursalı A., GÜRSES M., SUNER KARAKÜLAH A., KARAKÜLAH G., Mungan U., et al.

CANCER SCIENCE , cilt.115, sa.9, ss.2985-2997, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. **Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells**

Ozgun G., Yaras T., Akman B., Özden-Yılmaz G., Landman N., Karakülah G., et al.

CANCER GENE THERAPY , cilt.31, sa.4, ss.537-551, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. De novo transcriptome assembly of mouse male germ cells reveals novel genes, stage-specific bidirectional promoter activity, and noncoding RNA expression

Gill M. E., Rohmer A., ERKEK ÖZHAN S., Liang C., Chun S., Ozonov E. A., et al.

GENOME RESEARCH , cilt.33, sa.12, ss.2060-2078, 2023 (SCI-Expanded, Scopus)

7. Osimertinib resistance mechanisms in nonsmall cell lung cancer using focused CRISPR Screen: FOSL1 and JUN

Uluata-Dayanc B., ERİŞ S., Cakiroglu E., Ozden-Yilmaz G., Coskun-Deniz O. S., KARAKÜLAH G., et al.

FEBS OPEN BIO , cilt.13, ss.149-150, 2023 (SCI-Expanded)

8. MEDULLOBLASTOMA SUBGROUP-SPECIFIC CHROMATIN STATES REVEAL NOVEL THERAPEUTIC VULNERABILITIES

Tao R., Gao Q., Erkek S., Matsui Y., Djekidel N., Darrow E., et al.

NEURO-ONCOLOGY , cilt.25, 2023 (SCI-Expanded)

9. The paracaspase MALT1 is a downstream target of Smad3 and potentiates the crosstalk between TGF-β and NF-kB signaling pathways in cancer cells

Mazi F. A., Cakiroglu E., Uysal M., Kalyoncu M., Demirci D., Sozeri P. Y. G., et al.

CELLULAR SIGNALLING , cilt.105, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines

Özden-Yılmaz G., Savas B., Bursalı A., Eray A., Arıbaş A., ŞENTÜRK Ş., et al.

CELLS , cilt.12, sa.6, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer

Guneri-Sozeri P. Y., Özden-Yılmaz G., Kisim A., Cakiroglu E., Eray A., Uzuner H., et al.

COMMUNICATIONS BIOLOGY , cilt.6, sa.1, 2023 (SCI-Expanded, Scopus)

12. Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors

Bluemel L., Qin N., Berlandi J., Paisana E., Cascao R., Custodia C., et al.

CELL DEATH & DISEASE , cilt.13, sa.9, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer

Guneri-Sozeri P. Y., Erkek-Ozhan S.

MOLECULAR BIOLOGY REPORTS , cilt.49, sa.4, ss.3135-3147, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond

Ozgun G., ŞENTÜRK Ş., Erkek-Ozhan S.

INTERNATIONAL JOURNAL OF CANCER , cilt.148, sa.10, ss.2364-2374, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Classification of bladder cancer cell lines according to regulon activity

Eray A., Erkek-Ozhan S.

TURKISH JOURNAL OF BIOLOGY , cilt.45, sa.6, ss.656-672, 2021 (SCI-Expanded, Scopus, TRDizin)

16. Analysis of open chromatin regions in bladder cancer links β-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer

Eray A., Gueneri P. Y., Yilmaz G. O., Karakuelah G., Erkek-Ozhan S.

SCIENTIFIC REPORTS , cilt.10, sa.1, 2020 (SCI-Expanded, Scopus)

17. Mesane gen regülasyonunda etkili süper-enhancer’ların belirlenmesi

Erkek Özhan S.

Türk Hijyen ve Deneysel Biyoloji Dergisi , cilt.77, sa.1, ss.41-50, 2020 (Scopus)

18. Genomic basis for RNA alterations in cancer

Calabrese C., Davidson N. R., Demircioglu D., Fonseca N. A., He Y., Kahles A., et al.

NATURE , cilt.578, sa.7793, ss.129-178, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Pan-cancer analysis of whole genomes

Campbell P. J., Getz G., Korbel J. O., Stuart J. M., Jennings J. L., Stein L. D., et al.

NATURE , cilt.578, sa.7793, ss.82-131, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration

Chun H. E., Johann P. D., Milne K., Zapatka M., Buellesbach A., Ishaque N., et al.

CELL REPORTS , cilt.29, sa.8, ss.2338-2361, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation

ERKEK ÖZHAN S., Johann P. D., Finetti M. A., Drosos Y., Chou H., Zapatka M., et al.

CANCER CELL , cilt.35, sa.1, ss.95-118, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. InTAD: chromosome conformation guided analysis of enhancer target genes

Okonechnikov K., ERKEK ÖZHAN S., Korbel J. O., Pfister S. M., Chavez L.

BMC BIOINFORMATICS , cilt.20, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors

Tegeder I., Thiel K., ERKEK ÖZHAN S., Johann P. D., Berlandi J., Thatikonda V., et al.

JOURNAL OF NEURO-ONCOLOGY , cilt.141, sa.1, ss.43-55, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma

Lee C., Rudneva V. A., ERKEK ÖZHAN S., Zapatka M., Chau L. Q., Tacheva-Grigorova S. K., et al.

NATURE COMMUNICATIONS , cilt.10, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. The landscape of genomic alterations across childhood cancers

Groebner S. N., Worst B. C., Weischenfeldt J., Buchhalter I., Kleinheinz K., Rudneva V. A., et al.

NATURE , cilt.555, sa.7696, ss.321-343, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. **Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma**

Merk D. J., Ohli J., Merk N. D., Thatikonda V., Morrissy S., Schoof M., et al.

DEVELOPMENTAL CELL , cilt.44, sa.6, ss.709-730, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling

Mack S. C., Pajtler K. W., Chavez L., Okonechnikov K., Bertrand K. C., Wang X., et al.

NATURE , cilt.553, sa.7686, ss.101-121, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. The whole-genome landscape of medulloblastoma subtypes

Northcott P. A., Buchhalter I., Morrissy A. S., Hovestadt V., Weischenfeldt J., Ehrenberger T., et al.

NATURE , cilt.547, sa.7663, ss.311-330, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. **Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking**

Weischenfeldt J., Dubash T., Drainas A. P., Mardin B. R., Chen Y., Stuetz A. M., et al.

NATURE GENETICS , cilt.49, sa.1, ss.65-74, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Targeting Primary Ciliogenesis in Atypical Teratoid/Rhabdoid Tumors

Bluemel L., Kerl K., Picard D., Malzkorn B., Johann P. D., Erkek S., et al.

PEDIATRIC BLOOD & CANCER , cilt.63, 2016 (SCI-Expanded, Scopus)

31. Sperm is epigenetically programmed to regulate gene transcription in embryos

Teperek M., Simeone A., Gaggioli V., Miyamoto K., Allen G. E., ERKEK ÖZHAN S., et al.

GENOME RESEARCH , cilt.26, sa.8, ss.1034-1046, 2016 (SCI-Expanded, Scopus)

32. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

Johann P. D., ERKEK ÖZHAN S., Zapatka M., Kerl K., Buchhalter I., Hovestadt V., et al.

CANCER CELL , cilt.29, sa.3, ss.379-393, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Active medulloblastoma enhancers reveal subgroup-specific cellular origins

Lin C. Y., ERKEK ÖZHAN S., Tong Y., Yin L., Federation A. J., Zapatka M., et al.

NATURE , cilt.530, sa.7588, ss.57-76, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. ATYPICAL TERATOID/RHABDOID TUMORS ARE CHARACTERIZED BY HIGH LEVELS OF EZH2 AND DNMT THAT CORRELATE WITH DNA-METHYLATION AND ARE AMENABLE TO THERAPEUTIC INHIBITION

Kerl K., Johann P., Moreno N., Mertins J., Ahlfeld J., Erkek S., et al.

PEDIATRIC BLOOD & CANCER , cilt.62, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Disruption of histone methylation in developing sperm impairs offspring health transgenerationally

Siklenka K., ERKEK ÖZHAN S., Godmann M., Lambrot R., McGraw S., Lafleur C., et al.

SCIENCE , cilt.350, sa.6261, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism

Radford E. J., Ito M., Shi H., Corish J. A., Yamazawa K., Isganaitis E., et al.

SCIENCE , cilt.345, sa.6198, ss.785-793, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

Northcott P. A., Lee C., Zichner T., Stuetz A. M., ERKEK ÖZHAN S., Kawauchi D., et al.

NATURE , cilt.511, sa.7510, ss.428-446, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing

Hovestadt V., Jones D. T. W., Picelli S., Wang W., Kool M., Northcott P. A., et al.

NATURE , cilt.510, sa.7506, ss.537-553, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Genome-wide chromatin analysis in mature mouse and human spermatozoa

Hisano M., ERKEK ÖZHAN S., Dessus-Babus S., Ramos L., Stadler M. B., Peters A. H. F. M.

NATURE PROTOCOLS , cilt.8, sa.12, ss.2449-2470, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Na⁺/I^- Symporter and Type 3 Iodothyronine Deiodinase Gene Expression in Amniotic Membrane and Placenta and Its Relationship to Maternal Thyroid Hormones

AKTÜRK M. Y., Oruc A. S., Danisman N., ERKEK ÖZHAN S., Buyukkagnici U., Unlu E., et al.

BIOLOGICAL TRACE ELEMENT RESEARCH , cilt.154, sa.3, ss.338-344, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Coiled-Coil Domain Containing Protein 124 Is a Novel Centrosome and Midbody Protein That Interacts with the Ras-Guanine Nucleotide Exchange Factor 1B and Is Involved in Cytokinesis

Telkoparan P., Erkek S., Yaman E., Alotaibi H., Bayik D., Tazebay U. H.

PLOS ONE , cilt.8, sa.7, 2013 (SCI-Expanded, Scopus)

42. Molecular determinants of nucleosome retention at CpG-rich sequences in mouse spermatozoa

ERKEK ÖZHAN S., Hisano M., Liang C., Gill M., Murr R., Dieker J., et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY , cilt.20, sa.7, ss.868-877, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Parental epigenetic control of embryogenesis: a balance between inheritance and reprogramming?

Gill M. E., ERKEK ÖZHAN S., Peters A. H. F. M.

CURRENT OPINION IN CELL BIOLOGY , cilt.24, sa.3, ss.387-396, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Repressive and active histone methylation mark distinct promoters in human and mouse spermatozoa

Brykczynska U., Hisano M., ERKEK ÖZHAN S., Ramos L., Oakeley E. J., Roloff T. C., et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY , cilt.17, sa.6, ss.679-688, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 20

1. DIVERGENT MEDULLOBLASTOMA CHROMATIN STATES DISCLOSE KDM2B AS A NOVEL ONCOGENIC DEPENDENCY

Tao R., Erkek S., Matsui Y., Xu B., Smith K. S., Gao Q., et al.

International Symposium on Pediatric Neuro-Oncology (ISPNO), Pennsylvania, Amerika Birleşik Devletleri, 29 Haziran - 02 Temmuz 2024, cilt.26, (Özet Bildiri)

2. Nucleocytoplasmic β‐Catenin localization contributes to neuroendocrine differentiation in muscle-invasive bladder cancer

Akman B., Bursalı A., Gürses M., Suner Karakülah A., Karakülah G., Mungan M. U., et al.

16. Üroonkoloji Kongresi, Antalya, Türkiye, 8 - 12 Kasım 2023, ss.290, (Özet Bildiri) Sürdürülebilir Kalkınma

3. KDM6A shows distinct profiles in bladder

Özden Yılmaz G., Savaş B., Bursalı A., Eray A., Arıbaş A., Şentürk Ş., et al.

1st Epigenetics Society International Meeting “Epigenetics of Disease and Development”, Rome, İtalya, 12 - 14 Ekim 2023, ss.209-210, (Özet Bildiri)

4. PAN-CANCER MUTATION RATE ANALYSIS OF CHROMATIN MODIFIER GENES FREQUENTLY MUTATED IN BLADDER CANCER

ERKEK ÖZHAN S.

2. ULUSLARARASI TIP BİLİMLERİ VE MULTİDİSİPLİNER YAKLAŞIMLAR KONGRESİ, 10 - 11 Temmuz 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Revealing the Role of Retinoids On the Phenotypic and Epigenetic Landscape of Bladder Cancer Cells

Özgün G., ŞENTÜRK Ş., ERKEK ÖZHAN S.

6. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi, Ankara, Türkiye, 10 - 11 Nisan 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

6. İdrardan elde edilen ürotelyal kök hücreler ile mesane kanserinin epigenetik regülasyonunun belirlenmesi

Eray A., Ozden Yilmaz G., Guneri P. Y., ERKEK S.

Onkolojide İz Bırakanlar Zirvesi, Türkiye, 14 - 16 Kasım 2019, (Özet Bildiri)

7. Mesane Kanserlerinde Epigenetik Düzenlemeler

ERKEK S.

16. Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2019, (Özet Bildiri)

8. TARGETING PRIMARY CILIOGENESIS IN ATYPICAL TERATOID/RHABDOID TUMORS

Blümel L., Kerl K., Qin N., Berlandi J., Thiel K., Tegeder I., et al.

5th Biennial Conference on Pediatric Neuro-Oncology BASIC and TRANSLATIONAL RESEARCH, 3 - 04 Mayıs 2019, (Özet Bildiri)

9. INTEGRATIVE ANALYSES OF GENE REGULATORY LANDSCAPES REVEAL RHABDOID TUMOR SUBGROUPS WITH POSSIBLE IMMUNE MODULATION THROUGH EPIGENETIC DYSREGULATION

Johann P. D., HyeJung C., ERKEK S., Iskar M., Perlman E., Hasselblatt M., et al.

Society for Neuro-Oncology 2019 Pediatric Neuro-Oncology Basic and Translational Research Conference, San-Francisco, Kostarika, 3 - 04 Mayıs 2019, (Özet Bildiri)

10. Interplay Between SWI/SNF and Polycomb in Atypical TeratoidRhabdoid Tumors

ERKEK S.

6th International Congress of the Molecular Biology Association of Turkey, 5 - 08 Eylül 2018, (Özet Bildiri)

11. WHOLE GENOME AND EPIGENOME CHARACTERIZATION LINKS ATRT-MYC TO A SUBGROUP OF RENAL RHABDOID TUMORS

Johann P. D., Chun E., ERKEK ÖZHAN S., Iskar M., Perlman E., Hasselblatt M., et al.

18th International Symposium on Pediatric Neuro-Oncology, Denver, Amerika Birleşik Devletleri, 30 Haziran - 03 Temmuz 2018, (Özet Bildiri)

12. USING DROSOPHILA TO EXPLORE THE FUNCTIONAL RELEVANCE OF GENES AFFECTED BY EPIGENETIC ALTERATIONS IN ATYPICAL TERATOID/RHABDOID TUMORS (AT/RT)

Tegeder I., Thiel K., Berlandi J., Johann P. D., ERKEK S., Kool M., et al.

18th International Symposium on Pediatric Neuro-Oncology, Denver, 30 Haziran - 03 Temmuz 2018, (Özet Bildiri)

13. CHROMATIN SEGMENTATION IN ATRT REVEALS AN IMPORTANT ROLE FOR RESIDUAL SWI/SNF MEMBERS

Johann P., Erkek S., Finetti M., Hasselblatt M., Williamson D., Pfister S., et al.

18th International Symposium on Pediatric Neuro-Oncology (ISPNO), Colorado, Amerika Birleşik Devletleri, 30 Haziran - 03 Temmuz 2018, cilt.20, ss.33, (Özet Bildiri)

14. CHROMATIN SEGMENTATION ANALYSES IN ATYPICAL TERATOID/RHABDOID TUMORS REVEAL H3K27ME3-MEDIATED EPIGENETIC SILENCING OF TUMOR SUPPRESSOR GENES AND IDENTIFY A NOVEL ROLE OF EZH2, ASSOCIATED WITH ACTIVE CHROMATIN

Johann P. D., ERKEK S., Chavez L., Finetti M., Kerl K., Zapatka M., et al.

Society for Neuro-Oncology 2017 Pediatric Neuro-Oncology Basic and Translational Research Conference, New York, Amerika Birleşik Devletleri, 15 - 16 Haziran 2017, cilt.19, ss.3, (Özet Bildiri)

15. THE EPIGENETIC LANDSCAPE OF ATYPICAL TERATOID/ RHABDOID TUMORS REVEALS A REPRESSED METHYLOME AND EPIGENETIC SWITCHES AT SMARCB1 BINDING SITES

ERKEK ÖZHAN S., Johann P. D., Kerl K., Finetti M., Zapatka M., Michael C F., et al.

The 21st Annual Meeting and Education Day of the Society for NeuroOncology, Arizona, Amerika Birleşik Devletleri, 17 - 20 Kasım 2016, (Özet Bildiri)

16. SUBGROUP SPECIFIC ENHANCERS CONTROL DISTINCT REGULATORY CIRCUITRIES IN EPENDYMAL TUMORS

Chavez L., Pajtler K. W., Okonechnikov K., Groebner S., Erkek S., Huang Z., et al.

21st Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology, Arizona, Amerika Birleşik Devletleri, 17 - 20 Kasım 2016, cilt.18, ss.74-75, (Özet Bildiri)

17. Identification of novel oncogenic mechanisms in brain tumors with quiet genomes through mapping the enhancer landscape

ERKEK S., Pajtler K., Johann P. D., Northcott P. A., Chavez L., Kool M., et al.

AACR Annual Meeting, New Orleans, 16 - 20 Nisan 2016, (Özet Bildiri)

18. EPIGENOMIC ANALYSIS OF EPENDYMAL TUMORS IDENTIFIES SUBGROUP SPECIFIC ENHANCERS CONTROLLING DISTINCT REGULATORY CIRCUITRIES

Chavez L., Pajtler K., ERKEK ÖZHAN S., Witt H., Groebner S., Huang Z., et al.

International Symposium on Pediatric Neuro-Oncology, Liverpool, İngiltere, 12 - 17 Haziran 2016, (Özet Bildiri)

19. THE CHROMATIN LANDSCAPE OF MEDULLOBLASTOMA

ERKEK S., Zapatka M., Chavez L., Waszak S., Hovestadt V., Johann P. D., et al.

20th Annual Scientific Meeting of the Society for Neuro-Oncology, 19 - 22 Kasım 2015, (Özet Bildiri)

20. ATYPICAL TERATOID/RHABDOID TUMOUR IS A GENETICALLY HOMOGENEOUS BUT EPIGENETICALLY HETEROGENEOUS DISEASE THAT IS DEFINED BY SUBGROUP SPECIFIC SUPER-ENHANCERS

Johann P., Erkek S., Zapatka M., Kerl K., Buchhalter I., Hovestadt V., et al.

3rd Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research, California, Amerika Birleşik Devletleri, 7 - 08 Mayıs 2015, cilt.17, ss.1, (Özet Bildiri)

Kitaplar 1

1. Implications of Chromatin Modifier Mutations in Epigenetic Regulation of Bladder Cancer

Erkek Özhan S., Akman B.

Urologic Cancers, Neil Barber,Ahmed Ali, Editör, Exon Publications, Brisbane, ss.45-60, 2022

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

8493

H-İndeks (WoS)

Atıf (Scopus)

9092

H-İndeks (Scopus)

Atıf (Scholar)

12787

H-İndeks (Scholar)

Atıf (Sobiad)

H-İndeks (Sobiad)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler